Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | UNK | Unknown | PO / MO |
The patient took dose of Vivotif vaccine one consecutive days; Case reference number US-BN-2024-001747 is a spontaneous case report initially received from a pharmacist via Med Communications (reference number USBAV24-0615) on 01-Apr-2024 and concerns a patient of unspecified gender or age. The patient's medical history and concomitant medication details were not provided. On unspecified dates, the patient took unknown number of doses of Vivotif vaccine (batch number: unknown) orally, at unknown dose for unknown indication, as reported on consecutive days (explicitly coded as 'inappropriate schedule of vaccine administered'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif vaccine. No further information was provided.; Reporter's Comments: A patient of unspecified gender or age took unknown number of doses of Vivotif vaccine for unknown indication, as reported on consecutive days, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse event due to Vivotif vaccine. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A patient of unspecified gender or age took unknown number of doses of Vivotif vaccine for unknown indication, as reported on consecutive days, which is considered as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse event due to Vivotif vaccine. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administration has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None